Curis earnings matched, revenue fell short of estimates
Investing.com - Curis (NASDAQ: CRIS) reported second quarter EPS of $-0.1200, in line with the analyst estimate of $-0.1200. Revenue for the quarter came in at $2.2M versus the consensus...
Neutral
or
Curis News & Analysis
-
-
Analyst Holds Steady On Curis As FDA Removes Partial Clinical Hold On Leukemia Study
Thursday, the FDA removed the partial clinical hold on Curis Inc's (NASDAQ: CRIS) TakeAim Leukemia Phase 1/2 study of emavusertib for hematologic malignancies. Further, the recommended phase...
-
Curis Announces FDA Removes Partial Clinical Hold on TakeAim Leukemia Study RP2D Established at 300 mg BID
Curis, Inc., (Nasdaq: CRIS), a biotechnology company focused on the development of emavusertib, an orally available small molecule triple target inhibitor (IRAK4, FLT3 and CLK) for the...
-
Curis Prices 18.4M Share Offering at $0.82/sh
Curis, Inc. (Nasdaq: CRIS), a biotechnology company focused on the development of emavusertib, a triple target inhibitor (IRAK4, FLT3 and CLK) for the treatment of hematologic malignancies,...
-
Curis earnings matched, revenue fell short of estimates
Investing.com - Curis (NASDAQ: CRIS) reported first quarter EPS of $-0.120, in line with the analyst estimate of $-0.120. Revenue for the quarter came in at $2.3M versus the consensus...
-
Curis earnings beat by $0.01, revenue fell short of estimates
Investing.com - Curis (NASDAQ: CRIS) reported first quarter EPS of $-0.120, $0.01 better than the analyst estimate of $-0.130. Revenue for the quarter came in at $2.89M versus the consensus...
-
Curis Earnings beat, Revenue misses In Q3
Investing.com - Curis reported on Wednesday third quarter {{erl-15811||earnings that beat analysts' forecasts and revenue that fell short of expectations. Curis announced earnings per...
-
Curis Tops Q3 EPS by 3c
Curis (CRIS) reported Q3 EPS of ($0.14), $0.03 better than the analyst estimate of ($0.17). Revenue for the quarter came in at $2.83 million versus the consensus estimate of $2.95...
-
U.S. shares higher at close of trade; Dow Jones Industrial Average up 0.30%
Investing.com – U.S. equities were higher at the close on Monday, as gains in the Technology, Consumer Services and Consumer Goods sectors propelled shares higher. At the close in NYSE, the...
-
Midday Stock Movers: Twitter, Tesla, Hertz Rally, DWAC Continues Decline
By Sam Boughedda Investing.com -- U.S. Indices are up midday Monday, with the Nasdaq the biggest winner at +1.45% Monday, April 4th. Twitter (NYSE:TWTR) has surged Monday, trading 25%...
-
U.S. shares higher at close of trade; Dow Jones Industrial Average up 0.04%
Investing.com – U.S. equities were higher at the close on Friday, as gains in the Technology, Consumer Services and Consumer Goods sectors propelled shares higher. At the close in NYSE, the...
-
U.S. shares lower at close of trade; Dow Jones Industrial Average down 1.99%
Investing.com – U.S. equities were lower at the close on Wednesday, as losses in the Technology, Basic Materials and Consumer Services sectors propelled shares lower. At the close in NYSE,...
-
U.S. shares higher at close of trade; Dow Jones Industrial Average up 0.36%
Investing.com – U.S. equities were higher at the close on Tuesday, as gains in the Telecoms, Oil & Gas and Healthcare sectors propelled shares higher. At the close in NYSE, the Dow Jones...
-
U.S. shares mixed at close of trade; Dow Jones Industrial Average down 0.60%
Investing.com – U.S. equities were mixed at the close on Monday, as gains in the Consumer Goods, Utilities and Technology sectors propelled shares higher while losses in the Oil & Gas, Basic...
-
U.S. shares mixed at close of trade; Dow Jones Industrial Average up 0.06%
Investing.com – U.S. equities were mixed at the close on Monday, as gains in the Consumer Goods, Consumer Services and Industrials sectors propelled shares higher while losses in the...
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data. Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
